LegoChem Biosciences Inc (141080) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.093x

Based on the latest financial reports, LegoChem Biosciences Inc (141080) has a cash flow conversion efficiency ratio of -0.093x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-46.62 Billion ≈ $-31.60 Million USD) by net assets (₩500.52 Billion ≈ $339.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LegoChem Biosciences Inc market cap and net worth for the company's overall valuation and market capitalisation.

LegoChem Biosciences Inc - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how LegoChem Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

LegoChem Biosciences Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of LegoChem Biosciences Inc ranked by their cash flow conversion efficiency. Explore LegoChem Biosciences Inc earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Compania Cervecerias Unidas SA ADR NYSE:CCU	-0.006x
Electricity Generating Public Company Limited BK:EGCO	0.000x
Timah Persero Tbk JK:TINS	0.130x
Shandong Shida Shenghua Chem SHG:603026	0.029x
Shandong Iron and Steel Co Ltd SHG:600022	0.016x
Encore Capital Group Inc NASDAQ:ECPG	-0.027x
Elekta AB (publ) ST:EKTA-B	0.067x
Wuxi Huaguang Boiler Co Ltd SHG:600475	0.066x

Annual Cash Flow Conversion Efficiency for LegoChem Biosciences Inc (2014–2025)

The table below shows the annual cash flow conversion efficiency of LegoChem Biosciences Inc from 2014 to 2025. View 141080 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩541.12 Billion ≈ $366.71 Million	₩-124.53 Billion ≈ $-84.39 Million	-0.230x	-280.65%
2024-12-31	₩616.00 Billion ≈ $417.45 Million	₩78.48 Billion ≈ $53.18 Million	0.127x	+130.34%
2023-12-31	₩148.22 Billion ≈ $100.45 Million	₩-62.24 Billion ≈ $-42.18 Million	-0.420x	-1192.20%
2022-12-31	₩219.60 Billion ≈ $148.82 Million	₩-7.14 Billion ≈ $-4.84 Million	-0.032x	+80.00%
2021-12-31	₩258.77 Billion ≈ $175.37 Million	₩-42.05 Billion ≈ $-28.50 Million	-0.162x	-22.33%
2020-12-31	₩112.13 Billion ≈ $75.99 Million	₩-14.89 Billion ≈ $-10.09 Million	-0.133x	-162.66%
2019-12-31	₩113.75 Billion ≈ $77.09 Million	₩24.11 Billion ≈ $16.34 Million	0.212x	+268.92%
2018-12-31	₩101.66 Billion ≈ $68.90 Million	₩-12.76 Billion ≈ $-8.65 Million	-0.125x	+26.34%
2017-12-31	₩48.21 Billion ≈ $32.67 Million	₩-8.21 Billion ≈ $-5.57 Million	-0.170x	+21.52%
2016-12-31	₩60.06 Billion ≈ $40.70 Million	₩-13.04 Billion ≈ $-8.84 Million	-0.217x	-9.73%
2015-12-31	₩43.18 Billion ≈ $29.26 Million	₩-8.54 Billion ≈ $-5.79 Million	-0.198x	+49.69%
2014-12-31	₩20.04 Billion ≈ $13.58 Million	₩-7.88 Billion ≈ $-5.34 Million	-0.393x	--

About LegoChem Biosciences Inc

KQ:141080 Korea Biotechnology

Market Cap

$2.07 Billion

₩3.05 Trillion KRW

Market Cap Rank

#6041 Global

#143 in Korea

Share Price

₩83700.00

Change (1 day)

-1.18%

52-Week Range

₩77900.00 - ₩213500.00

All Time High

₩213500.00